Multinationals have positive views on Korean drug makers

Overall, foreign-invested pharmaceutical firms feel that domestic pharmaceutical firms have performed their business operations well in terms of production facilities, licensing procedures and sales activities, according to the Korea Health Industry Development Institute.

A KHIDI report said that Korean firms’ R&D capability, patent acquisition and marketing techniques have been relatively l...